Prosperity → 

R&D expenses

Largest private investor in R&D ​

Source : Commission for federal cooperation, Working group CFS/STAT; calculations Federal Science Policy Office, primary economic activity classification

R&D spending is a key indicator of how innovative an industry is, driving the technological advances that are vital for a sustainable future. R&D spending in the chemicals, plastics and life sciences industry totalled nearly 4.3 billion in 2017, an increase of 64% over a decade. The sector is the largest private investor in R&D, accounting for 65% of total R&D expenditure by all Belgian manufacturing companies in 2017. Life sciences companies account for 88% of the sector’s total R&D spending.

About 64% of R&D spending occurs in-house, with the balance spent by third parties on behalf of a client company. This high level of third-party spending reflects the strong degree of collaboration between companies and technology centres to boost innovation.    

The R&D intensity of the Belgian economy (in both the private and public sectors) amounted to 2.7% of GDP in 2017. The R&D intensity of the sector (expressed as in-house R&D spending/value added) reached 14.1% in the same period. Thanks to these efforts, the industry plays a key role in enabling Belgium to achieve the European target of investing 3% of GDP in R&D.

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

This website uses cookies to improve your browsing experience (optimize the site functionalities, share contents on social media and collect statistics). By continuing your online browsing on our website, you accept the use of such cookies.